Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3β and PI3K/Akt/mTOR-dependent mechanisms

International Journal of Biochemistry and Cell Biology

Volumn 37, Issue 10 SPEC. ISS., 2005, Pages 2207-2216

  Li, Bing Guo ^a   Hasselgren, Per Olof ^b   Fang, Cheng Hui ^a  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cell signaling; Dexamethasone; IGF I; L6 myotubes; Proteolysis

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; DEXAMETHASONE; INITIATION FACTOR 4E BINDING PROTEIN 1; LITHIUM CHLORIDE; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P70; RAPAMYCIN; SOMATOMEDIN C; THIADIAZOLE DERIVATIVE; TRANSCRIPTION FACTOR FOXO; TRICHLOROACETIC ACID; TYROSINE;

ANIMAL CELL; BIOSYNTHESIS; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; MYOTUBE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RADIOACTIVITY; RAT;

EID: 23944504285     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2005.04.008     Document Type: Conference Paper

References (33)

1. T. Abribat, P. Brazau, I. Davignon, and D.R. Garriel Insulin-like growth factor-I blood levels in severely burned patients: effects of time post injury, age of patient and severity of burn Clin. Endocrinol. 39 1993 583 589
2. S.C. Bodine, T.N. Stitt, M. Gonzalez, W.O. Kline, G.L. Stover, and R. Bauerlein Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo Nat. Cell. Biol. 3 2001 1014 1019
3. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
4. E. Chalecka-Franaszek, and D.M. Chuang Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 in neurons Proc. Natl. Acad. Sci. U.S.A. 96 1999 8745 8750
5. W.G. Cioffi, D.C. Gore, L.W. Rue, G. Carrougher, H.P. Guler, and W.F. McManus Insulin-like growth factor-I lowers protein oxidation in patients with thermal injury Ann. Surg. 220 1994 310 319
6. S.P. Davies, H. Reddy, M. Caivano, and P. Cohen Specificity and mechanism of action of some commonly used protein kinase inhibitors Biochem. J. 351 2000 95 105
7. C.H. Fang, J.H. James, J.E. Fischer, and P.O. Hasselgren Influence of burn injury on protein metabolism in different types of skeletal muscle and the role of glucocorticoids J. Am. Coll. Surg. 180 1995 33 42
8. C.H. Fang, B.G. Li, J.J. Wang, J.E. Fischer, and P.O. Hasselgren Insulin-like growth factor 1 stimulates protein synthesis and inhibits protein breakdown in muscle from burned rats J. Parenter Enteral Nutr. 21 1997 245 251
9. C.H. Fang, B.G. Li, J.J. Wang, J.E. Fischer, and P.O. Hasselgren Treatment of burned rats with insulin-like growth factor I inhibits the catabolic response in skeletal muscle Am. J. Physiol. 275 1998 R1091 R1098
10. C.H. Fang, B.G. Li, C.J. Wray, and P.O. Hasselgren Insulin-like growth factor-I inhibits lysosomal and proteasome-dependent proteolysis in skeletal muscle after burn injury J. Burn Care Rehabil. 23 2002 318 325
11. S. Ferrari, and G. Thomas S6 phosphorylation and the p70s6k/p85s6k Crit. Rev. Biochem. Mol. Biol. 29 1994 385 413
12. P.O. Hasselgren Glucocorticoids and muscle catabolism Curr. Opin. Clin. Nutr. Metab. Care 2 1999 201 205
13. P.O. Hasselgren, and J.E. Fischer Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation Ann. Surg. 233 2001 9 17
14. D.H. Hong, and N.E. Forsberg Effects of dexamethasone on protein degradation and protease gene expression in rat L8 myotube cultures Mol. Cell Endocrinol. 108 1995 199 209
15. R.E. Humbel Insulin-like growth factors I and II Eur. J. Biochem. 190 1990 445 462
16. C.H. Lang, X. Liu, G.J. Nystrom, and R.A. Frost Acute response of IGF-I and IGF-I binding proteins by thermal injury Am. J. Physiol. 278 2000 E1087 E1096
17. C.H. Lang, G.J. Nystrom, and R.A. Frost Burn-induced changes in IGF-I and IGF-binding proteins are partially glucocorticoid dependent Am. J. Phsyiol. 282 2002 R207 R215
18. S.H. Lecker, R.T. Jagoe, A. Gilbert, M.D. Gomes, V. Baracos, and J. Bailey Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression FASEB J. 18 2004 39 51
19. B.G. Li, P.O. Hasselgren, C.H. Fang, and G.D. Warden Insulin-like growth factor-I blocks dexamethasone-induced protein degradation in cultured myotubes by inhibiting multiple proteolytic pathways J. Burn Care Rehabil. 25 2004 112 118
20. G. Luo, D.D. Hershko, B.W. Robb, C.J. Wray, and P.O. Hasselgren IL-1beta stimulates IL-6 production in cultured skeletal muscle cells through activation of MAP kinase signaling pathway and NF-kB Am. J. Physiol. 284 2003 R1249 R1254
21. A. Martinez, M. Alonso, A. Castro, C. Perez, and F.J. Moreno First non-ATP competitive glycogen synthase kinase 3β (GSK-3β) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease J. Med. Chem. 45 2002 1292 1299
22. M.E. Patti, E. Brambilla, L. Luzi, E.J. Landaker, and C.R. Kahn Bidirectional modulation of insulin action by amino acids J. Clin. Invest. 101 1998 1519 1529
23. C. Rommel, S.C. Bodine, B.A. Clarke, R. Rossman, L. Nunez, and T.N. Stitt Mediation of IGF-I-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways Nat. Cell Biol. 3 2001 1009 1013
24. J.B. Rubin, M.A. Shia, and P.F. Pilch Stimulation of tyrosine-specific phosphorylation in vitro by insulin-like growth factor I Nature 305 1983 438 440
25. W.J. Ryves, and A.J. Harwood Lithium inhibits glycogen synthase kinase-3 by competition for magnesium Biochem. Biophys. Res. Commun. 280 2001 720 725
26. J.M. Sacheck, A. Ohtsuka, S.C. McLary, and A.L. Goldberg IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1 Am. J. Physiol. 287 2004 E591 E601
27. M. Sandri, C. Sandri, A. Gilbert, C. Skurk, E. Calabria, and A. Picard Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy Cell 117 2004 399 412
28. T. Schmelzle, and M.N. Hall TOR, a central controller of cell growth Cell 103 2000 253 262
29. T.N. Stitt, D. Drijan, B.A. Clarke, F. Panaro, Y. Timofeyva, and W.O. Kline The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors Mol. Cell 14 2004 395 403
30. L.L. Strock, H. Singh, A. Abdullah, J.A. Miller, and D.N. Herndon The effect of insulin-like growth factor I on postburn hypermetabolism Surgery 108 1990 161 164
31. T. Tsakiridis, E. Tsiani, P. Lekas, A. Bergman, V. Cherepanov, and C. Whiteside Insulin, insulin-like growth factor-I, and platelet-derived growth factor activate extracellular signal-regulated kinase by distinct pathways in muscle cells Biochem. Biophys. Res. Commun. 288 2001 205 211
32. D.R. Vyas, E.E. Spangenburg, T.W. Abraham, T.E. Childs, and F.W. Booth GSK-3β negatively regulates skeletal myotube hypertrophy Am. J. Physiol. Cell Physiol. 283 2002 C545 C551
33. L. Wang, G.J. Luo, J.J. Wang, and P.O. Hasselgren Dexamethasone stimulates proteasome- and calcium-dependent proteolysis in cultured L6 myotubes Shock 10 1998 298 306